ABT
Abbott Laboratories
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ABT
- PE Ratio
The current PE ratio for Abbott Laboratories stock as of Jun 9, 2026 is 25.42. This is calculated based on the current EPS of $3.59 and the stock price of $91.25 per share. The P/E ratio has an increase of 6% from the past four quarters average of 24.0.
ABT PE ratio history
The average historical PE ratio of Abbott Laboratories for the last ten years is 50.29. The current PE ratio of 25.42 is 49% below the historical average. Over the past ten years, ABT's PE ratio was at its highest in the Mar 2018 quarter at 230.46, when the stock price was $59.92 and the EPS was $0.26. The lowest value was in the Dec 2024 quarter, when it reached 14.75 with a price of $113.11 and an EPS of $7.67.
Abbott Laboratories PE ratio by year
Maximum annual increase: 417.3% in 2017
Maximum annual decrease: -74.46% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 33.59 | 127.73% | $125.29 | $3.73 |
| 2024 | 14.75 | -56.05% | $113.11 | $7.67 |
| 2023 | 33.56 | 20.42% | $110.07 | $3.28 |
| 2022 | 27.87 | -21.38% | $109.79 | $3.94 |
| 2021 | 35.45 | -18.41% | $140.74 | $3.97 |
| 2020 | 43.45 | 3.55% | $109.49 | $2.52 |
| 2019 | 41.96 | -22.27% | $86.86 | $2.07 |
| 2018 | 53.98 | -74.46% | $72.33 | $1.34 |
| 2017 | 211.37 | 417.3% | $57.07 | $0.27 |
| 2016 | 40.86 | 167.41% | $38.41 | $0.94 |
| 2015 | 15.28 | -49.08% | $44.91 | $2.94 |
| 2014 | 30.01 | 28.41% | $45.02 | $1.5 |
| 2013 | 23.37 | 34.16% | $38.33 | $1.64 |
| 2012 | 17.42 | -6.14% | $65.5 | $3.76 |
| 2011 | 18.56 | 15.42% | $56.23 | $3.03 |
Abbott Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 28.6 | -14.86% | $102.67 | $3.59 |
| Dec 2025 | 33.59 | 100.66% | $125.29 | $3.73 |
| Sep 2025 | 16.74 | -1.53% | $133.94 | $8 |
| Jun 2025 | 17 | -1.05% | $136.01 | $8 |
| Mar 2025 | 17.18 | 16.47% | $132.65 | $7.72 |
| Dec 2024 | 14.75 | -57.31% | $113.11 | $7.67 |
| Sep 2024 | 34.55 | 5.72% | $114.01 | $3.3 |
| Jun 2024 | 32.68 | -7.13% | $103.91 | $3.18 |
| Mar 2024 | 35.19 | 4.86% | $113.66 | $3.23 |
| Dec 2023 | 33.56 | 2.22% | $110.07 | $3.28 |
| Sep 2023 | 32.83 | -11.17% | $96.85 | $2.95 |
| Jun 2023 | 36.96 | 20.82% | $109.02 | $2.95 |
| Mar 2023 | 30.59 | 9.76% | $101.26 | $3.31 |
| Dec 2022 | 27.87 | 28.73% | $109.79 | $3.94 |
| Sep 2022 | 21.65 | -3.73% | $96.76 | $4.47 |
ABT Price vs fair value
ABT average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
ABT's current P/E ratio is below the 3, 5 and 10-year averages.
PE comparison
Abbott Laboratories's P/E of 25.42 is above the Healthcare sector and its peers average but below the industry average. Compared to its Healthcare sector average of 24.1, Abbott Laboratories's P/E is 5% higher.
ABT PE vs peers
Compared to its peers JNJ and AZN, ABT's PE ratio stands lower, however it is higher than NVS's and PFE's. Abbott Laboratories's PE ratio is trading above the peer group average of 22.67.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol Myers Squibb Co | 15.82 | $115.34B |
| PFE Pfizer Inc | 19.62 | $146.48B |
| BSX Boston Scientific Corp | 20.32 | $72.77B |
| NVS Novartis AG | 21.24 | $284.53B |
| MDT Medtronic plc | 22.77 | $105.25B |
| ABT Abbott Laboratories | 25.42 | $158.94B |
| TMO Thermo Fisher Scientific Inc | 27.12 | $183.61B |
| JNJ Johnson & Johnson | 27.15 | $570.51B |
| AZN Astrazeneca plc | 27.34 | $284.13B |
Frequently asked questions
What is Abbott Laboratories's PE ratio?
As of Jun 9, 2026, ABT stock has a price to earnings ratio of 25.42.
What is the 3-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 3 years is 27.8.
What is the 5-year average PE ratio for Abbott Laboratories (ABT)?
The average PE ratio for ABT stock over the past 5 years is 28.02.
What is the highest PE ratio for ABT?
Over the last ten years, the quarterly PE ratio reached a historic high of 230.46 in the Mar 2018 quarter.
How does the current PE ratio for ABT compare to its historical average?
The current price to earnings ratio of ABT is 49% lower than the 10-year historical average.
How is ABT's PE ratio calculated (Abbott Laboratories PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 9, 2026), Abbott Laboratories's stock price is $91.25. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $3.59. Therefore, Abbott Laboratories's P/E ratio for today is 25.42. PE RATIO(25.42) = STOCK PRICE($91.25) / TTM EPS($3.59)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.